BRK-B vs DHY
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
DHY presents as a classic high-yield trap, characterized by a stable Piotroski F-Score of 5/9 but severely deteriorating fundamentals. While the Graham Number of $2.4 suggests a defensive fair value above the current price of $1.76, this is offset by a growth-based intrinsic value of $0.84 and a catastrophic earnings decline of 28% YoY. The most critical concern is the unsustainable dividend payout ratio of 155%, combined with a completely bearish technical trend (0/100) and dangerously low liquidity ratios.
Compare Another Pair
Related Comparisons
BRK-B vs DHY: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and Credit Suisse High Yield Credit Fund (DHY) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.